New Type 2 Diabetes Drug Approved - DSMDiabetes Self-Management
One of the main proteins responsible for this reabsorption is SGLT2. By inhibiting the action of SGLT2, Farxiga blocks the ...
SGLT2 Inhibitors Reduce Risk for Gout in Type 2 - DSMDiabetes Self-Management
Want to learn more about SGLT2 inhibitors? Read "Diabetes Medicine: SGLT2 Inhibitors."[11] ... SGLT2 inhibitors linked to lower gout risk. The researchers found that the overall incidence of gout was 20.3 per 1,000 person- ... In fact, one SGLT2 inhibitor - Farxiga (dapagliflozin) - was approved[8] in April 2021 in the United States as a treatment for ... The group of type 2 diabetes[1] drugs known as SGLT2 inhibitors[2] may help reduce the risk for gout - a form of arthritis ...